NFKB1 and lung adenocarcinoma: On the other hand, sublethal concentrations of ACRO caused a biphasic activation on NF-κB activation in A549 human lung adenocarcinoma cells, NF-κB decreasing dramatically at 1–2 h post-treatment and returning to near normal binding by 8–12 h [83].